Nanosonics Ltd reported a 17% increase in revenue to $198.6 million in 2025, driven by growth in recurring revenue and innovation in infection prevention technologies.

Nanosonics Ltd’s market capitalization has surged to $1.2 billion after receiving multiple US FDA clearances for its next-generation disinfection technologies.